BLC
CLX icon

Brown, Lisle/Cummings’s Clorox CLX Stock Holding History

Brown, Lisle/Cummings’s Portfolio CLX Stock Details CLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$331K Buy
3,463
+1,365
+65% +$131K 0.07% 192
2026
Q1 		$217K Buy
2,098
+287
+16% +$32.5K 0.05% 203
2025
Q4 		$183K Hold
1,811
– – 0.05% 219
2025
Q3 		$223K Sell
1,811
-325
-15% -$40.3K 0.06% 202
2025
Q2 		$256K Buy
2,136
+89
+4% +$11.9K 0.07% 191
2025
Q1 		$301K Buy
2,047
+9
+0.4% +$1.37K 0.09% 179
2024
Q4 		$331K Hold
2,038
– – 0.1% 175
2024
Q3 		$332K Hold
2,038
– – 0.1% 172
2024
Q2 		$278K Hold
2,038
– – 0.09% 177
2024
Q1 		$312K Hold
2,038
– – 0.11% 165
2023
Q4 		$291K Hold
2,038
– – 0.11% 170
2023
Q3 		$267K Buy
2,038
+800
+65% +$122K 0.12% 154
2023
Q2 		$197K Buy
1,238
+800
+183% +$129K 0.09% 180
2023
Q1 		$69.3K Hold
438
– – 0.04% 248
2022
Q4 		$61.5K Hold
438
– – 0.03% 249
2022
Q3 		$56.2K Hold
438
– – 0.03% 246
2022
Q2 		$61.7K Hold
438
– – 0.03% 238
2022
Q1 		$60.9K Hold
438
– – 0.03% 248
2021
Q4 		$76.4K Buy
+438
New +$73K 0.04% 230

Other funds holding CLX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Brown, Lisle/Cummings's CLX Position: Q2 2026 in Review

Brown, Lisle/Cummings increased its Clorox (CLX) stake by 65% in Q2 2026, buying an estimated $131K and bringing the position to 3,463 shares worth $331K. The position accounts for 0.07% of the portfolio, ranked #192.

Brown, Lisle/Cummings first reported a position in CLX in Q4 2021 and has held it in 19 quarters since. The position peaked at $332K in Q3 2024. 1,046 funds tracked by Wall St. Rank hold CLX as of Q2 2026.

  • Brown, Lisle/Cummings held 3,463 shares of Clorox worth $331K as of Q2 2026.
  • Brown, Lisle/Cummings bought 1,365 Clorox shares in Q2 2026, an estimated $131K.
  • Clorox made up 0.07% of Brown, Lisle/Cummings's portfolio in Q2 2026, its #192 holding.
  • Brown, Lisle/Cummings first reported a position in Clorox in Q4 2021 and has held it in 19 quarters since.
  • Brown, Lisle/Cummings's Clorox position peaked at $332K in Q3 2024.
  • 1,046 funds tracked by Wall St. Rank held Clorox as of Q2 2026.

Based on Brown, Lisle/Cummings's 13F filing for Q2 2026, filed 2 Sep 2026.